Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Appropriate drug dosing in obese patients and patients after bariatric surgery
- In: D14 What’s new in industry and science? Part 1 on Monday, 3 September 2018, 16:50 -17:00
- At: Glasgow (Scotland) (2018)
- Type: Presentation
- By: DE LEEUW, Marc (Royal Dutch Pharmacists Association (KNMP), The Netherlands)
- Co-author(s): Marc De Leeuw
Froukje Harkes-Idzinga : , Royal Dutch Pharmacists Association (KNMP) , The Hague , Netherlands
Mandy van Rhenen: , Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands
Maaike de Wit : , Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands
Catherijne Knibbe: , St. Antonius Hospital , Nieuwegein, Netherlands
Desirée Burgers: , St. Antonius Hospital, Nieuwegein, Netherlands
Fong Sodihardjo-Yuen: , Royal Dutch Pharmacists Association (KNMP) , The Hague, Netherlands
Mariska van der Ham: , Royal Dutch Pharmacists Association (KNMP) , The Hague, Netherlands - Abstract:
Background
Obesity and morbidly obesity is a growing health problem in many countries including the Netherlands. Particularly for (morbidly) obese patients with risk factors such as diabetes, weight-reducing or bariatric surgery is increasingly considered as treatment option. While changes may be expected in absorption, distribution, metabolism
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023